SCLX FY 2024 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

FY 2024 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$57M+21.1% YoY

Gross Profit

$40M70.5% margin

Operating Income

-$83M-147.4% margin

Net Income

-$73M-128.7% margin

EPS (Diluted)

$-19.43

Cash Flow

Operating Cash Flow

$19M

Free Cash Flow

$19M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$93M

Total Liabilities

$286M

Stockholders' Equity

-$193M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57M	$47M	+21.1%
Gross Profit	$40M	$31M	+28.5%
Operating Income	-$83M	-$105M	+20.9%
Net Income	-$73M	-$114M	+36.3%